94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
STUDY PROTOCOL article
Front. Oncol.
Sec. Breast Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1496741
Efficacy of Thunder-Fire Moxibustion for Cancer-Related Fatigue in Breast Cancer Survivors: Study Protocol for a Randomized Controlled Trial
Provisionally accepted
Huakang Li 1
Zhonglin Zhang 2 Qiang Li 3 Yuyang Jin 4 Yunjing Jia 1 Pengxuan Gu 1 Qi Xiao 3 Lingna Jin 3 Ziliang Wu 2
Bing Lin 3* Shanshan Wei 2*
Jinyi Lang 2- 1 Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China
- 2 Sichuan Cancer Hospital, Chengdu, Sichuan Province, China
- 3 Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China
- 4 Chengdu Sport University, Chengdu, Sichuan Province, China
Background: Cancer-related fatigue (CRF) is one of the most prevalent and debilitating symptoms experienced by breast cancer survivors, often associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. In China, moxibustion is widely used as a therapeutic approach for managing fatigue. Thunder-fire moxibustion (TFM), a novel technique with high thermal radiation and strong penetrative properties, may provide benefits for CRF. This study aims to assess the efficacy, safety, and underlying mechanisms of TFM in the treatment of CRF among breast cancer survivors.Methods: This prospective, single-center, open-label, randomized controlled trial will recruit 70 breast cancer survivors diagnosed with CRF. Participants will be randomly assigned in a 1:1 ratio to either a waitlist control group or a TFM intervention group.All participants will receive standard care during the 30-day treatment period. Those in the TFM group will additionally undergo TFM treatment every other day, totaling 15 sessions. The primary outcome measure is the change in total fatigue score, assessed using the Piper Fatigue Scale, from baseline to the end of treatment. Additionally, this study will investigate the underlying mechanisms of TFM by evaluating changes in HPA axis-related hormone levels, inflammatory markers, gut microbiota composition, and conducting metabolomic analyses of fecal and blood samples.Discussion: This study takes a multidisciplinary approach to comprehensively explore how TFM modulates biological systems involved in CRF, aiming to generate robust evidence. If successful, this study will provide high-quality, evidence-based reference points for the treatment of CRF in breast cancer survivors and inform future research in integrative medicine.The study has been registered with the International Traditional Medicine Clinical Trial Registry (http://itmctr.ccebtcm.org.cn, ITMCTR2024000406).
Keywords: Moxibustion, Cancer-related fatigue, breast cancer, randomized controlled trial, Clinical trial protocol
Received: 03 Jan 2025; Accepted: 20 Feb 2025.
Copyright: © 2025 Li, Zhang, Li, Jin, Jia, Gu, Xiao, Jin, Wu, Lin, Wei and Lang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Bing Lin, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China
Shanshan Wei, Sichuan Cancer Hospital, Chengdu, 610041, Sichuan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.